Study to Evaluate the Mass Babance and Biotransformation of [14C]SHR6390 in Healthy Adult Male Volunteers

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Healthy Adult Male Volunteers Clinical Trial

Official title:
A Phase I Mass Balance and Biotransformation Study of [14C]SHR6390 in Chinese Healthy Adult Male Volunteers.

Status Completed

Clinical Trial Summary

Study to Evaluate the mass balance and biotransformation of single dose [14C]SHR6390 in Chinese healthy adult male volunteers.

n/a

NCT number	NCT04616742
Study type	Interventional
Source	Jiangsu HengRui Medicine Co., Ltd.
Contact
Status	Completed
Phase	Phase 1
Start date	November 11, 2020
Completion date	May 1, 2021

See also
Status	Clinical Trial	Phase
Completed	`NCT04873063` - Evaluation of Systemic Bioavailability and Effects on 24-Hour Plasma Cortisol Profile of 6 mg Delivered Once Daily Versus 3 mg Delivered Twice Daily in Healthy Adult Male Volunteers	Phase 1
Completed	`NCT05059743` - ADME Study of [14C]- Larotinib in Healthy Male Subjects	Phase 1
Completed	`NCT04260373` - Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR4640 in Chinese Healthy Adult Male Volunteers.	Phase 1
Active, not recruiting	`NCT05095337` - Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR1459 in Healthy Adult Male Volunteers	Phase 1
Completed	`NCT05150717` - ADME Study of [14C]-Jaktinib in Healthy Male Subjects	Phase 1
Completed	`NCT05109078` - ADME Study of [14C]- Rongliflozin in Healthy Male Subjects	Phase 1